Moderna | MRNA - Trade Creditors



Moderna reported $175M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Adcock Ingram Holdings 1.16B 941.66M Jun/2024
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Celltrion KRW 106.69B 31.38B Mar/2025
Cspc Pharmaceutical CNY 2.04B 548.01M Dec/2024
Dianthus Therapeutics USD 5.4M 825K Jun/2025
Divis Laboratories Ltd 9.1B 550M Mar/2025
Gilead Sciences USD 582M 155M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Kangmei Pharma CNY 2.43B 2.26M Jun/2025
Laboratorios Farma EUR 57.21M 29.64M Jun/2025
Malin Corporation EUR 0 500K Dec/2024
Moderna USD 175M 51M Jun/2025
Organigram Holdings 89.8M 26.46M Jun/2025
Pharma Mar EUR 37.08M 4.92M Jun/2025
Qiagen NV USD 82.34M 12.67M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Sartorius EUR 384.2M 24.6M Jun/2025
Sino Biopharmaceutical CNY 1.5B 685.94M Dec/2024
Tilray USD 99.08M 2.79M Nov/2024
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
United Therapeutics 432M 426M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025
Zz Pientze Pharmaceu 484.61M 53.88M Jun/2025